Concord Drugs Financials Statements

Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios

Consolidate

Standalone


Total Qtr Revenue cr	37.90	16.99	10.28	13.61	10.40
Other Income Qtr Cr	0.01	0.02	0.00	0.00	0.00
Operating Revenues Qtr	37.89	16.97	10.28	13.61	10.39
Loading chart...
Operating Expenses Qtr	36.40	16.04	9.18	12.59	9.35
Operating Profit Qtr	1.49	0.92	1.10	1.02	1.04
EBITDA Qtr Cr	1.50	0.94	1.10	1.02	1.05
Depreciation Qtr	0.35	0.31	0.34	0.37	0.38
Net Profit Qtr	0.53	0.22	0.19	0.12	0.04
Basic EPS Qtr	0.47	0.16	0.19	0.12	0.04

Open Demat Account